Cynthia García-Sánchez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Cynthia García-Sánchez has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
- Gilberto Vargas-Alarcón
Research Direction, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City 14080, Mexico
6 shared publications - Elizabeth Carreón-Torres
Department of Molecular Biology, Instituto Nacional de Cardiología Ignacio Chávez, Juan Badiano 1, Sección XVI, Tlalpan, Mexico City 14080, Mexico
5 shared publications - Oscar Pérez-Méndez
Department of Molecular Biology, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City 14080, Mexico
4 shared publications Carlos Posadas-Romero
Department of Endocrinology, Instituto Nacional de Cardiología "Ignacio Chávez", Mexico
3 shared publicationsAnat R. Tambur
Transplant Immunology Laboratory Comprehensive Transplant Center Northwestern University Chicago Illinois USA
2 shared publicationsCristhel López-Osorio
Department of Molecular Biology, Instituto Nacional de Cardiología “Ignacio Chávez”, México City, Mexico
2 shared publications
Latest Publications
- 28 June 2021
- Published by Wiley in Clinical Transplantation
- Vol. 35 (9)
Impact of SIRPα polymorphism on transplant outcomes in HLA‐identical living donor kidney transplantation
Signal‐regulatory protein α (SIRPα), a polymorphic inhibitory membrane‐bound receptor, and its ligand CD47 have recently been implicated in the modulation of innate immune allorecognition in murine models.Here, we investigate the potential impact of SIRPα donor‐recipient mismatches on graft outcomes in human kidney transplantation. To eliminate the specific role of HLA‐matching in alloresponse, we genotyped the two most common variants of SIRPα in a cohort of 55 HLA‐identical, biologically‐related, donor‐recipient pairs. 69% of pairs were SIRPα identical. No significant differences were found between donor‐recipient SIRPα‐mismatch status and T cell‐mediated rejection/borderline changes (25.8% vs. 25%) or slow graft function (15.8% vs. 17.6%). A trend towards more graft failure (GF) (23.5% vs. 5.3%, P = .06), interstitial inflammation (50% vs. 23%, P = .06) and significant changes in peritubular capillaritis (ptc) (25% vs. 0%, P = .02) were observed in the SIRPα‐mismatched group. Unexpectedly, graft‐versus‐host (GVH) SIRPα‐mismatched pairs exhibited higher rates of GF and tubulitis (38% vs. 5%, P = .031 and .61 ± .88 vs. 0, P = .019; respectively).Whether the higher prevalence of ptc in SIRPα‐mismatched recipients and the higher rates of GF in GVH SIRPα‐mismatched pairs represent a potential role for SIRPα in linking innate immunity and alloimmune rejection requires further investigation in larger cohorts.
- 28 June 2021
- Published by Wiley in Clinical Transplantation
- Vol. 35 (9)
Impact of SIRPα polymorphism on transplant outcomes in HLA‐identical living donor kidney transplantation
Signal‐regulatory protein α (SIRPα), a polymorphic inhibitory membrane‐bound receptor, and its ligand CD47 have recently been implicated in the modulation of innate immune allorecognition in murine models.Here, we investigate the potential impact of SIRPα donor‐recipient mismatches on graft outcomes in human kidney transplantation. To eliminate the specific role of HLA‐matching in alloresponse, we genotyped the two most common variants of SIRPα in a cohort of 55 HLA‐identical, biologically‐related, donor‐recipient pairs. 69% of pairs were SIRPα identical. No significant differences were found between donor‐recipient SIRPα‐mismatch status and T cell‐mediated rejection/borderline changes (25.8% vs. 25%) or slow graft function (15.8% vs. 17.6%). A trend towards more graft failure (GF) (23.5% vs. 5.3%, P = .06), interstitial inflammation (50% vs. 23%, P = .06) and significant changes in peritubular capillaritis (ptc) (25% vs. 0%, P = .02) were observed in the SIRPα‐mismatched group. Unexpectedly, graft‐versus‐host (GVH) SIRPα‐mismatched pairs exhibited higher rates of GF and tubulitis (38% vs. 5%, P = .031 and .61 ± .88 vs. 0, P = .019; respectively).Whether the higher prevalence of ptc in SIRPα‐mismatched recipients and the higher rates of GF in GVH SIRPα‐mismatched pairs represent a potential role for SIRPα in linking innate immunity and alloimmune rejection requires further investigation in larger cohorts.
- 17 May 2020
- Published by Wiley in Clinical Transplantation
- Vol. 34 (8) , e13906
The shared epitope phenomenon—A potential impediment to virtual crossmatch accuracy
With the implementation of the new kidney allocation system (KAS), there is increased reliance on a virtual crossmatch/histocompatibility risk assessment (vXM) for evaluating potential presence, as well as strength, of HLA antibodies against a potential donor. The accuracy of such an assessment depends on the precision in the identification of the recipient's antibody profile and the potential donor's HLA typing. While the development of the single antigen bead (SAB) multiplex assay has improved the sensitivity and specificity of HLA antibody detection, several limitations of the assay (specific to certain sensitized patients) can complicate accurate interpretation of results. In this report, we focus on the “shared‐epitope” phenomenon, a condition in which antibody strength can be underrepresented, or its presence completely missed, due to binding of the antibody to competing targets on multiple antigens (beads), effectively “diluting” the resulting MFI readout. Here, we provide a relevant background to understand this phenomenon and present a couple of case studies illustrating how it can be investigated, leading to a more accurate histocompatibility consultation.
- 17 May 2020
- Published by Wiley in Clinical Transplantation
- Vol. 34 (8) , e13906
The shared epitope phenomenon—A potential impediment to virtual crossmatch accuracy
With the implementation of the new kidney allocation system (KAS), there is increased reliance on a virtual crossmatch/histocompatibility risk assessment (vXM) for evaluating potential presence, as well as strength, of HLA antibodies against a potential donor. The accuracy of such an assessment depends on the precision in the identification of the recipient's antibody profile and the potential donor's HLA typing. While the development of the single antigen bead (SAB) multiplex assay has improved the sensitivity and specificity of HLA antibody detection, several limitations of the assay (specific to certain sensitized patients) can complicate accurate interpretation of results. In this report, we focus on the “shared‐epitope” phenomenon, a condition in which antibody strength can be underrepresented, or its presence completely missed, due to binding of the antibody to competing targets on multiple antigens (beads), effectively “diluting” the resulting MFI readout. Here, we provide a relevant background to understand this phenomenon and present a couple of case studies illustrating how it can be investigated, leading to a more accurate histocompatibility consultation.
CETP and LCAT Gene Polymorphisms Are Associated with High‐Density Lipoprotein Subclasses and Acute Coronary Syndrome
We evaluated whether CETP and LCAT gene polymorphisms are statistically associated with the high‐density lipoprotein (HDL) size distribution, the cholesterol level of HDL subclasses, and the acute coronary syndrome (ACS) susceptibility. Two CETP gene polymorphisms (rs4783961 and rs708272) and one LCAT polymorphism (rs2292318) were genotyped by 5′ exonuclease TaqMan assays in 619 patients with ACS and 607 control individuals. For HDL analysis, a subgroup of 100 healthy individuals was recruited; the HDL subclasses were separated via ultracentrifugation and polyacrylamide gradient gel electrophoresis under native conditions. Under a dominant model, the G allele of the rs708272 polymorphism was associated with an increased risk of ACS (odds ratios [OR] = 1.45, corrected p‐value [pCDom] = 0.036). The linkage disequilibrium analysis showed that one of the eight possible combinations was associated with the risk of developing ACS (OR = 1.52, pC = 0.02), which suggests that it may contribute to coronary atherosclerosis. The rs708272 G allele carriers had a lower concentration of cholesterol associated with the HDL2a and HDL3a subclasses when compared with subjects carrying the A allele. Carriers of LCAT rs2292318 A allele showed a lower concentration of high‐density lipoprotein‐cholesterol (HDL‐C) in comparison to the GG genotype; the cholesterol associated with the each one of the five HDL subclasses was significantly lower in rs2292318 A than in GG subjects. In summary, this study demonstrates that the rs708272 polymorphism is associated with a heightened risk of developing ACS. In addition, we report the association of the rs708272 and rs2292318 polymorphisms with HDL‐C levels and HDL subclasses.
CETP and LCAT Gene Polymorphisms Are Associated with High‐Density Lipoprotein Subclasses and Acute Coronary Syndrome
We evaluated whether CETP and LCAT gene polymorphisms are statistically associated with the high‐density lipoprotein (HDL) size distribution, the cholesterol level of HDL subclasses, and the acute coronary syndrome (ACS) susceptibility. Two CETP gene polymorphisms (rs4783961 and rs708272) and one LCAT polymorphism (rs2292318) were genotyped by 5′ exonuclease TaqMan assays in 619 patients with ACS and 607 control individuals. For HDL analysis, a subgroup of 100 healthy individuals was recruited; the HDL subclasses were separated via ultracentrifugation and polyacrylamide gradient gel electrophoresis under native conditions. Under a dominant model, the G allele of the rs708272 polymorphism was associated with an increased risk of ACS (odds ratios [OR] = 1.45, corrected p‐value [pCDom] = 0.036). The linkage disequilibrium analysis showed that one of the eight possible combinations was associated with the risk of developing ACS (OR = 1.52, pC = 0.02), which suggests that it may contribute to coronary atherosclerosis. The rs708272 G allele carriers had a lower concentration of cholesterol associated with the HDL2a and HDL3a subclasses when compared with subjects carrying the A allele. Carriers of LCAT rs2292318 A allele showed a lower concentration of high‐density lipoprotein‐cholesterol (HDL‐C) in comparison to the GG genotype; the cholesterol associated with the each one of the five HDL subclasses was significantly lower in rs2292318 A than in GG subjects. In summary, this study demonstrates that the rs708272 polymorphism is associated with a heightened risk of developing ACS. In addition, we report the association of the rs708272 and rs2292318 polymorphisms with HDL‐C levels and HDL subclasses.
- 1 February 2015
- Published by Elsevier in Atherosclerosis
- Vol. 238 (2) , 250-255
Low concentrations of phospholipids and plasma HDL cholesterol subclasses in asymptomatic subjects with high coronary calcium scores
- 1 February 2015
- Published by Elsevier in Atherosclerosis
- Vol. 238 (2) , 250-255
Low concentrations of phospholipids and plasma HDL cholesterol subclasses in asymptomatic subjects with high coronary calcium scores
- 1 December 2012
- Published by Elsevier in Clinica Chimica Acta
- Vol. 414, 241-245
Shift of high-density lipoprotein size distribution toward large particles in patients with proteinuria
- 1 December 2012
- Published by Elsevier in Clinica Chimica Acta
- Vol. 414, 241-245
Shift of high-density lipoprotein size distribution toward large particles in patients with proteinuria
- 1 April 2012
- Published by SAGE Publications in Metabolic Syndrome and Related Disorders
- Vol. 10 (2) , 110-116
The Srb1+1050T Allele Is Associated with Metabolic Syndrome in Children but Not with Cholesteryl Ester Plasma Concentrations of High-Density Lipoprotein Subclasses
Background: Low cholesterol and phospholipid plasma levels of some high-density lipoprotein (HDL) subclasses have been described in children with metabolic syndrome. Scavenger receptor class B type I (SR-BI) has been proposed to be at the origin of such HDL alterations because of its key role on cholesteryl esters–HDL metabolism. However, the possible contribution of SR-BI has not been specifically explored in this kind of patients. Methods: Plasma lipid concentrations of HDL subclasses, i.e., triglycerides (TG), phosphatidylcholine (Ph), free cholesterol (FC), and total cholesterol (TC), were determined by enzymatic staining on polyacrylamide gradient gels (PAGE) in 39 pediatric patients with metabolic syndrome and 65 children as controls. Cholesteryl esters were estimated by the difference between TC and FC. Proteins of HDL subclasses were also stained for the assessment of the relative size distribution of HDL. For statistical analysis, the study population was grouped by Srb1 +1050C-->T polymorphism (rs5888) as carriers or noncarriers of the T allele, and data were corrected by metabolic syndrome status. Results: The Srb1 +1050T allele was associated with metabolic syndrome [odds ratio (OR)=2.18 (1.12–4.22), P=0.02]. Plasma TG corresponding to HDL3a, as well as the relative proportion of this HDL subclass, were slightly higher in carriers of the T allele as compared to CC homozygous subjects. Cholesteryl esters plasma concentrations of all HDL subclasses were comparable between T allele carriers and noncarriers after correction by metabolic syndrome status. Conclusions : Srb1 +1050T was associated with metabolic syndrome, but T carrier subjects did not show important differences concerning HDL subclasses as compared to noncarriers.
- 1 April 2012
- Published by SAGE Publications in Metabolic Syndrome and Related Disorders
- Vol. 10 (2) , 110-116
The Srb1+1050T Allele Is Associated with Metabolic Syndrome in Children but Not with Cholesteryl Ester Plasma Concentrations of High-Density Lipoprotein Subclasses
Background: Low cholesterol and phospholipid plasma levels of some high-density lipoprotein (HDL) subclasses have been described in children with metabolic syndrome. Scavenger receptor class B type I (SR-BI) has been proposed to be at the origin of such HDL alterations because of its key role on cholesteryl esters–HDL metabolism. However, the possible contribution of SR-BI has not been specifically explored in this kind of patients. Methods: Plasma lipid concentrations of HDL subclasses, i.e., triglycerides (TG), phosphatidylcholine (Ph), free cholesterol (FC), and total cholesterol (TC), were determined by enzymatic staining on polyacrylamide gradient gels (PAGE) in 39 pediatric patients with metabolic syndrome and 65 children as controls. Cholesteryl esters were estimated by the difference between TC and FC. Proteins of HDL subclasses were also stained for the assessment of the relative size distribution of HDL. For statistical analysis, the study population was grouped by Srb1 +1050C-->T polymorphism (rs5888) as carriers or noncarriers of the T allele, and data were corrected by metabolic syndrome status. Results: The Srb1 +1050T allele was associated with metabolic syndrome [odds ratio (OR)=2.18 (1.12–4.22), P=0.02]. Plasma TG corresponding to HDL3a, as well as the relative proportion of this HDL subclass, were slightly higher in carriers of the T allele as compared to CC homozygous subjects. Cholesteryl esters plasma concentrations of all HDL subclasses were comparable between T allele carriers and noncarriers after correction by metabolic syndrome status. Conclusions : Srb1 +1050T was associated with metabolic syndrome, but T carrier subjects did not show important differences concerning HDL subclasses as compared to noncarriers.
- 1 January 2011
- Published by Elsevier in Clinica Chimica Acta
- Vol. 412 (3-4) , 292-298
Lipid plasma concentrations of HDL subclasses determined by enzymatic staining on polyacrylamide electrophoresis gels in children with metabolic syndrome
- 1 January 2011
- Published by Elsevier in Clinica Chimica Acta
- Vol. 412 (3-4) , 292-298
Lipid plasma concentrations of HDL subclasses determined by enzymatic staining on polyacrylamide electrophoresis gels in children with metabolic syndrome
- Open Access
- 1 June 2010
- Published by Elsevier in Journal of Lipid Research
- Vol. 51 (6) , 1610-1617
Enzymatic assessment of cholesterol on electrophoresis gels for estimating HDL size distribution and plasma concentrations of HDL subclasses
- 1 June 2010
- Published by Elsevier in Journal of Lipid Research
- Vol. 51 (6) , 1610-1617
Open AccessEnzymatic assessment of cholesterol on electrophoresis gels for estimating HDL size distribution and plasma concentrations of HDL subclasses